Status:
COMPLETED
Minimizing Narcotic Analgesics After Endocrine Surgery
Lead Sponsor:
Minerva A Romero Arenas
Conditions:
Thyroid Cancer
Thyroid Nodule
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This research is being done to better understand and test if the investigators can minimize narcotic medication for controlling pain after thyroid or parathyroid surgery. This research will be perform...
Detailed Description
A study team member will give the participant a copy of the informed consent form to read. Participants will have a chance to ask questions about the study before agreeing to participate. If participa...
Eligibility Criteria
Inclusion
- Adult patients 18 years of age or older,
- Who are undergoing thyroid or parathyroid surgery at DHR by an Endocrine Surgery faculty member,
- Provide informed consent to participate in the study in English or Spanish,
- Patients will be included if they are discharged the same day or on postoperative day 1,
- Patients who undergo central lymphadenectomy will be included,
- Patients who undergo two operations within a 2-week period (for example a thyroid lobectomy followed by subsequent completion thyroidectomy) will only have the postoperative narcotic requirements following the initial operation included for the study analysis.
- Patients who have a complication, such as seroma or hematoma, requiring return to the operating room within 48 hours will be included in the study for the initial operation only.
Exclusion
- Patients who undergo lateral neck lymph node dissection will be excluded from the study due to the extent of the operation requiring a different analgesic regimen;
- Patients allergic to any of the study drugs will be ineligible;
- Patients who undergo two operations within a 2-week period (for example a thyroid lobectomy followed by subsequent completion thyroidectomy) will only have the initial operation included for the study analysis.
- Patients with a formal diagnosis of hepatic failure will be ineligible
- Patients with any diagnosis of chronic pain requiring treatment with ongoing narcotic regimen will be ineligible
Key Trial Info
Start Date :
March 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 2 2020
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT03469310
Start Date
March 9 2018
End Date
October 2 2020
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GME General Surgery Clinic
Edinburg, Texas, United States, 78539